Shares of biotechnology company Moderna Inc. experienced a rare rally on Tuesday, with investors enjoying their first gain in two weeks. This positive movement came after the company announced that the first participant had been dosed in a Phase 3 trial of its combination vaccine candidate against the flu and COVID-19 in the U.S. Adding to the optimistic sentiment, ARK Genomic … [Read more...] about Moderna Inc. Sees Stock Rally as Phase 3 Trial Begins
Vaccine
Pfizer Introduces Penbraya: The First Five-in-One Meningococcal Vaccine
Pfizer Inc. has announced the approval of Penbraya, an innovative five-in-one vaccine by the U.S. Food and Drug Administration. This groundbreaking vaccine is designed to protect teenagers and young adults against meningococcal disease, a rare but potentially fatal illness that mostly affects babies and adolescents. Comprehensive Protection in a Single Shot Penbraya offers … [Read more...] about Pfizer Introduces Penbraya: The First Five-in-One Meningococcal Vaccine
UK Inoculation Program Provides Glimpse of COVID-19 Vaccine Effectiveness
The United Kingdom's inoculation program has provided a glimpse on the effectiveness of vaccines against the COVID-19 pandemic, with data compiled and put into charts by CNBC. Vaccines made by Pfizer-BioNTech were the first approved and rolled out in December, followed by Oxford-AstraZeneca.Deaths falling fastest in the over-85 age group in Scotland after first vaccinations … [Read more...] about UK Inoculation Program Provides Glimpse of COVID-19 Vaccine Effectiveness
